Nothing Special   »   [go: up one dir, main page]

CH593266A5 - - Google Patents

Info

Publication number
CH593266A5
CH593266A5 CH1140174A CH1140174A CH593266A5 CH 593266 A5 CH593266 A5 CH 593266A5 CH 1140174 A CH1140174 A CH 1140174A CH 1140174 A CH1140174 A CH 1140174A CH 593266 A5 CH593266 A5 CH 593266A5
Authority
CH
Switzerland
Application number
CH1140174A
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of CH593266A5 publication Critical patent/CH593266A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1140174A 1973-09-20 1974-08-21 CH593266A5 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (1)

Publication Number Publication Date
CH593266A5 true CH593266A5 (nl) 1977-11-30

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1140174A CH593266A5 (nl) 1973-09-20 1974-08-21

Country Status (12)

Country Link
US (1) US3978055A (nl)
JP (1) JPS5088079A (nl)
CA (1) CA1008074A (nl)
CH (1) CH593266A5 (nl)
DE (1) DE2444426A1 (nl)
ES (1) ES429869A1 (nl)
GB (1) GB1430729A (nl)
IT (1) IT1062796B (nl)
LU (1) LU70791A1 (nl)
NL (1) NL7412494A (nl)
SE (1) SE410600B (nl)
SU (1) SU645569A3 (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
CA2517166A1 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists
US8455489B2 (en) 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
PT1689715E (pt) * 2003-12-03 2011-05-16 Ym Biosciences Australia Pty Inibidores da tubulina
CN111423417B (zh) * 2012-11-21 2022-11-15 Ptc医疗公司 取代的反向嘧啶Bmi-1抑制剂
JP6524094B2 (ja) 2013-08-30 2019-06-05 ピーティーシー セラピューティクス, インコーポレイテッド 置換ピリミジンBmi−1阻害剤
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
EP3836932A2 (en) 2018-08-17 2021-06-23 PTC Therapeutics, Inc. Method for treating pancreatic cancer
US20220143016A1 (en) * 2019-02-28 2022-05-12 Ptc Therapeutics, Inc. Method for treating a multiple myeloma
CN114096537A (zh) * 2019-03-27 2022-02-25 Ptc医疗公司 肉瘤治疗方法的有用组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
AU7344174A (en) 1976-03-25
NL7412494A (nl) 1975-03-24
ES429869A1 (es) 1976-10-01
IT1062796B (it) 1985-01-31
US3978055A (en) 1976-08-31
SE410600B (sv) 1979-10-22
SU645569A3 (ru) 1979-01-30
JPS5088079A (nl) 1975-07-15
CA1008074A (fr) 1977-04-05
GB1430729A (en) 1976-04-07
DE2444426A1 (de) 1975-03-27
LU70791A1 (nl) 1975-06-11
SE7411806L (nl) 1975-03-21

Similar Documents

Publication Publication Date Title
AR201235Q (nl)
AR201231Q (nl)
JPS5088079A (nl)
AR201229Q (nl)
AR199451A1 (nl)
AU477823B2 (nl)
AR195948A1 (nl)
AR201432A1 (nl)
AR195311A1 (nl)
AU477824B2 (nl)
AR196382A1 (nl)
AR200885A1 (nl)
AR200256A1 (nl)
AR193950A1 (nl)
AR197627A1 (nl)
AU447540B2 (nl)
AR196123Q (nl)
AR196212Q (nl)
BG19568A1 (nl)
AU479521A (nl)
CH559909A5 (nl)
CH564417A5 (nl)
CH1753673A4 (nl)
BG19608A2 (nl)
CH564644A5 (nl)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased